Figure 1
Kaplan Meier Survival Curves for Ixazomib In Vivo Studies. There was a significant survival benefit in the ixazomib treatment groups (N=7) compared with the control groups (N=7) in Jurkat and L540 (P=0.001, LogRank, GraphPad Prism5).
Kaplan Meier Survival Curves for Ixazomib In Vivo Studies. There was a significant survival benefit in the ixazomib treatment groups (N=7) compared with the control groups (N=7) in Jurkat and L540 (P=0.001, LogRank, GraphPad Prism5).
